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The CAS (Crk-associated substrate) adaptor protein family consists of four members: CASS1/BCAR1/p130Cas,
CASS2/NEDD9/HEF1/Cas-L, CASS3/EFS/Sin and CASS4/HEPL. While CAS proteins lack enzymatic activity, they con-
tain speciﬁc recognition and binding sites for assembly of larger signaling complexes that are essential for cell pro-
liferation, survival, migration, and other processes. All family members are intermediates in integrin-dependent
signaling pathways mediated at focal adhesions, and associate with FAK and SRC family kinases to activate down-
stream effectors regulating the actin cytoskeleton. Most studies of CAS proteins to date have been focused on the
ﬁrst two members, BCAR1 and NEDD9, with altered expression of these proteins now appreciated as inﬂuencing
disease development and prognosis for cancer and other serious pathological conditions. For these familymembers,
additional mechanisms of action have been deﬁned in receptor tyrosine kinase (RTK) signaling, estrogen receptor
signaling or cell cycle progression, involving discrete partner proteins such as SHC, NSP proteins, or AURKA. By con-
trast, EFS and CASS4 have been less studied, although structure–function analyses indicate they conserve many
elements with the better-known family members. Intriguingly, a number of recent studies have implicated these
proteins in immune system function, and the pathogenesis of developmental disorders, autoimmune disorders in-
cluding Crohn's disease, Alzheimer's disease, cancer and other diseases. In this review, we summarize the current
understanding of EFS and CASS4 protein function in the context of the larger CAS family group.
© 2015 Elsevier B.V. All rights reserved.
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